Iroko Pharmaceuticals Selects Bottomline for Global Transactional Document Initiative

• Press Release
• Source: Bottomline Technologies
• On 10:25 am EDT, Thursday October 15, 2009

PORTSMOUTH, N.H.--(BUSINESS WIRE)--Bottomline Technologies (NASDAQ: EPAY - News), a leading provider of collaborative payment, invoice and document automation solutions, today announced that Iroko Pharmaceuticals, a global company focused on maximizing the potential of marketed pharmaceutical products, has selected Bottomline to extend and drive new capabilities from its Microsoft Dynamics® AX 2009 implementation.

Related Quotes

Symbol	Price	Change
EPAY	15.32	-0.68

{"s" : "epay","k" : "c10,l10,p20,t10","o" : "","j" : ""}

“Given our global client base and multiple company divisions, we needed a highly efficient and cost-effective approach to producing documents which meet the many country-specific requirements we are subject to,” said Michael Burke, Manager-Financial Analysis of Iroko Pharmaceuticals. “Bottomline’s capabilities provide the flexibility we desire without a costly or time-consuming implementation, and eliminate the need for custom programming every time changes are required to be made to transactional documents and forms.”

Bottomline’s award-winning document process automation solutions allow organizations to streamline business processes that rely heavily on paper-based documents. By automating the routing, delivery and storage of transactional documents such as invoices, payments and purchase orders, organizations can operate more efficiently and cost-effectively. Integrating with industry-leading enterprise resource planning (ERP) systems, Bottomline’s solutions enable users to manage electronic documents across multiple communication channels.

“We have established a track record for providing flexible and cost-effective solutions that allow organizations running Microsoft Dynamics AX to achieve new levels of automation, flexibility and capability,” said Rick Bell, Senior Vice President and General Manager of Bottomline Technologies. “We’re delighted to welcome Iroko Pharmaceuticals to Bottomline and are confident our solution set will enable them to drive global improvements in their business processes.”

Calculate the Environmental Savings

To help raise awareness of the environmental benefits achieved by transitioning from paper to electronic processing, Bottomline has posted a green savings calculator on its Web site at: www.bottomline.com/gogreen.

About Iroko Pharmaceuticals

Iroko is a pharmaceutical company focused on acquiring, developing, and maximizing the potential of currently marketed pharmaceutical products on a worldwide basis. Iroko applies concentrated selling and marketing efforts and product life cycle management strategies focused on developing new and relevant formulations and indications that benefit patient health. For more information, visit www.iroko.com.

About Bottomline Technologies

Bottomline Technologies (NASDAQ: EPAY - News) provides collaborative payment, invoice and document automation solutions to corporations, financial institutions and banks around the world. The company’s solutions are used to streamline, automate and manage processes involving payments, invoicing, global cash management, supply chain finance and transactional documents. Organizations trust these solutions to meet their needs for cost reduction, competitive differentiation and optimization of working capital. Headquartered in the United States, Bottomline also maintains offices in Europe and Asia-Pacific. For more information, visit www.bottomline.com.

Cautionary Language

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are competition, market demand, technological change, strategic relationships, recent acquisitions, international operations and general economic conditions. For additional discussion of factors that could impact Bottomline Technologies' financial results, refer to the Company's Form 10-K filed September 2009 and any recently filed Form 8-Ks. Any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. We do not assume any obligation to update any forward-looking statements.

Bottomline Technologies
Billy Balfour, 603-501-5219
bbalfour@bottomline.com